Acutis Names Abdel Halim, PharmD, MSc, PhD, DABCC, FAACC as Chief Scientific Officer

Diagnostic firm adds precision medication innovator to important leadership situation, continues to invest in Senior Talent to guidance its mission.

HICKSVILLE, N.Y., May well 24, 2022 /PRNewswire/ — Acutis, a specialised clinical and biosciences company, introduced Dr. Abdel Halim has joined as Main Scientific Officer and Govt Vice President for biopharma and diagnostics products and services.  Dr. Halim is a globally regarded pro in most cancers molecular profiling, precision drug improvement and diagnostic biomarker improvement with in excess of 25 a long time of encounter.  A person of only 4 laboratory researchers in the place to be triple board certified, Dr. Halim is regarded by the health-related community as well as regulators for his know-how and contributions to precision drugs and diagnostic development. 

Dr. Halim will progress our strategic eyesight to improve affected person care and make on our observe report of excellence.

At Acutis, Dr. Halim will offer scientific management to progress medical product or service growth, cancer genomics and biopharma services.  He has authored 65+ peer-reviewed articles or blog posts, sent 110 presentations and, most not too long ago, printed a single-creator reference e-book on biomarkers, precision medicine and diagnostics in drug development.  Dr. Halim has led biomarker, diagnostic and precision medicine factors in 150+ phase 1 to phase 3 clinical trials belonging to 40+ development programs with contributions to clinical demo design and style, conduct, analysis and interpretation.  Above his job, he has served on 20+ CLSI committees to create medical and laboratory rules authored 12 of them.  Dr. Halim is accredited by the Fda as a 3rd-social gathering reviewer of 510k submissions.

“We are thrilled to welcome Dr. Halim to advance our strategic eyesight to enhance affected individual treatment with most cancers diagnostics and in the distinctive value proposition we are setting up for the biopharma sector to incorporate scientific advancements in genomics and proteomics into the drug progress process,” Jibreel Sarij, Chief Executive Officer, stated. “Our vision builds on a observe document of execution excellence with around 3 million medical samples reported.”

Commenting on his appointment, Dr. Halim shared, “I was drawn to the eyesight that Acutis has, and which I share, to make improvements to client results by leveraging the newest science and progress in precision medicine technologies.  I am psyched to even more the groundbreaking work getting put alongside a gifted group of gurus at Acutis.”

About Acutis:

Acutis is a specialized medical and biosciences diagnostics grounded in the most highly developed science, technology, and greatest procedures, all established in movement by groups of deeply committed pros.

Call: Tara Gearheart: [email protected]

Cision View initial information to obtain multimedia:

Supply Acutis Diagnostics Inc.